# Explore AI in Addiction Science: Behavioral Addictions, Recovery & Harm Reduction

## Overview

Addiction science spans substance use disorders (SUDs) and behavioral addictions (gambling, gaming, internet, food), requiring intervention across prevention, treatment, and recovery phases. AI is now applied at every stage—from detecting addictive behaviors early to personalizing relapse prevention and supporting harm reduction. This document examines AI applications in addiction science, covering both substance and behavioral addictions, with emphasis on recovery support and harm reduction strategies.

## Key Technologies

**Predictive Modeling for Addiction Onset and Relapse**
- Machine learning classifiers on EHR, genetic, and environmental data to predict SUD risk
- Deep learning on smartphone usage patterns to detect compulsive app/screen use
- Temporal sequence models (LSTMs, Transformers) predicting relapse from daily monitoring data
- Wearable AI detecting physiological correlates of craving (skin conductance, HRV)

**Digital Therapeutics for Addiction**
- FDA-cleared prescription digital therapeutics (reSET, reSET-O for opioid and stimulant addiction)
- CBT-based chatbot apps with contingency management (e.g., recovered, WEConnect)
- VR-based cue exposure therapy with adaptive difficulty controlled by ML stress detection
- AI-driven contingency management platforms optimizing reward schedules

**Behavioral Addiction Detection**
- App usage analytics and digital phenotyping for internet gaming disorder detection
- Social media usage pattern analysis for compulsive behavior signatures
- Computer vision detecting problematic gaming/screen behaviors from screen recordings
- Mouse/keystroke dynamics as biomarkers of online gambling addiction

**Harm Reduction & Overdose Prevention**
- AI-optimized fentanyl test strip interpretation and drug checking services
- Predictive models for opioid overdose hotspot mapping (geospatial ML)
- NLP analysis of drug user forums and darknet markets for trend detection
- Naloxone deployment optimization using predictive risk models

## Current State

**reSET-O (Pear Therapeutics)** — FDA-authorized prescription digital therapeutic for opioid use disorder, delivering contingency management and CBT via smartphone. Studies show 40.5% opioid abstinence rates vs 17.6% for standard treatment at 12 weeks (full trial: *Lancet*, 2018).

**DynamiCare Health** — A digital health platform using AI-driven incentives for sobriety, integrated with smart breathalyzers and GPS monitoring. Deployed with Medicaid populations in multiple states.

**Bicycle Health** — Online OUD (opioid use disorder) treatment combining buprenorphine prescribing with an AI-augmented app that monitors recovery progress and flags risk, enabling same-week intervention.

**Chess.com / BetterUP - Gaming Disorder Detection** — Researchers at Nottingham Trent University developed ML models using mouse movement patterns during chess play to detect compulsive gaming behaviors with 86% accuracy. More broadly, game usage telemetry analyzed by AI is being used by platforms to self-regulate and comply with WHO gaming disorder guidelines.

**Yale CRAFFT Screening AI** — Adaptation of the adolescent substance abuse screening tool into a conversational AI that administers the full CRAFFT interview via chatbot, reducing stigma and increasing disclosure rates.

**Frontline Data / ODMap** — CDC-funded overdose mapping tool using ML to predict emerging overdose hotspots based on EMS calls, law enforcement seizures, and social media signals, enabling proactive harm reduction resource deployment.

**Woebot for Substance Use** — Woebot's parent company partnered with the Recovery Research Institute to develop a version tailored to individuals in recovery, providing daily check-ins, craving tracking, and skill practice.

**Cambridge University / Google AI Addiction Research** — Collaboration analyzing anonymized location and app usage data at population scale to identify digital addiction patterns and associations with mental health co-morbidities.

## Real-World Applications

- **Sober living monitoring**: AI-integrated sober living homes use wearable sensors and smart home monitoring to track resident behavior, detecting potential substance use events before they escalate.
- **Workplace addiction recovery**: Employee assistance programs (EAPs) like Compsych and Aetna use AI to identify employees at high risk of impairment and connect them with treatment earlier.
- **Prison reentry support**: AI tools helping individuals leaving incarceration navigate SUD treatment access, housing, and employment—critical windows for relapse prevention.
- **Youth gambling detection**: AI monitoring of betting app usage patterns in the UK (GambleAware) flags at-risk youth for intervention before significant harm accumulates.
- **Drug checking services**: AI-assisted FTIR (Fourier Transform Infrared) spectroscopy analysis identifies unknown substances in drug samples, with results integrated into harm reduction apps like GetTheFacts and DanceSafe.

## Challenges

**Data scarcity and stigma**: People with addiction are less likely to seek help and more likely to have fragmented or stigmatized health records, limiting training data for ML models.

**Regulatory complexity**: Addiction treatment is heavily regulated (SAMHSA, 42 CFR Part 2 for substance use records). AI systems must navigate strict confidentiality requirements that limit data sharing.

**Contingency management controversy**: AI-driven financial incentives for sobriety (contingency management) are effective but face legal/ethical questions about coercion and inducement.

**Behavioral addiction boundaries**: Internet gaming disorder and internet use disorder are still contested diagnoses. AI models trained on provisional diagnostic criteria may reinforce premature pathologization of normative behavior.

**Relapse prediction false positives**: A false positive relapse prediction could inappropriately trigger intervention in someone who is fine, causing anxiety and disrupting recovery trust.

**Equity**: AI tools for addiction may disproportionately reach technology-literate populations, leaving behind those most affected by addiction (homeless, incarcerated, low-income).

## Future Directions

**Brain-computer interfaces for addiction**: Early-stage research combining EEG-based BCIs with AI that can detect and potentially interrupt craving states in real time using neurofeedback.

**Generative AI for recovery coaching**: LLM-based recovery coaches trained on AA/NA literature, motivational interviewing principles, and harm reduction frameworks that provide 24/7 support between human sponsor contacts.

**Precision addiction medicine**: Using polygenic risk scores, metabolomics, and digital phenotyping together to match individuals to the optimal treatment (medication-assisted treatment vs. behavioral therapy vs. their combination).

**Decentralized harm reduction**: AI-powered chatbots that provide real-time drug checking advice, overdose response instructions, and connection to nearby harm reduction services—meeting people where they are.

**Multi-stakeholder addiction AI ecosystems**: Integrated systems linking emergency departments, harm reduction organizations, criminal justice, and recovery communities through shared AI infrastructure, enabling coordinated response.

## References

-uros, J., et al. (2018). Efficacy of a digital therapeutic for the treatment of opioid use disorder. *The Lancet*, 392(10149), 747–761.
- FDA. (2018). reSET-O® Opioid Use Disorder Digital Therapeutic — Approval Summary.
- Lindhiem, O., et al. (2021). Digital phenotyping of substance use. *Drug and Alcohol Dependence*, 218, 108412.
- Ives-Deliperi, V., et al. (2023). Machine learning prediction of relapse in alcohol use disorder. *Addiction Biology*, 28(1), e13255.
- Garnett, C., et al. (2022). Digital interventions for alcohol use disorders. *Nature Digital Medicine*, 5, 1–10.
- Rumpf, H. J., et al. (2022). Internet gaming disorder and gaming disorder in adolescents. *Current Addiction Reports*, 9, 1–12.
